• Register Today!
  • Final Agenda Available
  • Posters
  • Sponsorship

Globally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.

Conference Programs Include:

IMT Track Button 3 IMT Track Button 1 IMT Track Button 2

Featured Speakers:

Carl AlvingCarl Alving, Chief, Adjuvant & Antigen Research, Walter Reed Army Institute of Research

Robert Johnson Robert Johnson, Director, Regulatory Affairs, NIAID, NIH

Simon DelagraveSimon Delagrave, Senior Director & Head, Virology Research, Sanofi Pasteur

 Lakshmi_KrishnanLakshmi Krishnan, Director & Program Leader, National Research Council-Human Health Therapeutics, Canada

Derek-HaganDerek O’Hagan, Head, Global Discovery Support & New Technologies, GlaxoSmithKline Vaccines

Laurent HumeauLaurent Humeau, Vice President, R&D, Inovio Pharmaceuticals

Nicholas JacksonNicholas Jackson, Vice President, Head of Research, Sanofi Pasteur

 Shan LuShan Lu, Professor, University of Massachusetts

 Nikolai PetrovskyNikolai Petrovsky, Professor, Flinders University

Jeffrey UlmerJeffrey Ulmer, Head, Preclinical R&D, GlaxoSmithKline Vaccines



For more details on the conference, please contact:
Virginia Maxwell
Senior Associate Producer
T: (+1) 781-972-5436
For exhibit & sponsorship opportunities, please contact:
Uma Patel
Business Development Manager
T: (+1) 781-972-1349




Each year, ImVacS brings vaccine professionals together from around the world to discuss the crucial issues surrounding vaccine development. Along with presenting a snapshot of where vaccines stand today, the meeting also provides an important venue for networking, information exchange, and establishing collaborations.

The “Novel Vaccines” meeting explores how vaccine development is being innovated in order to create more efficacious vaccines, such as using Systems Biology or Reverse Vaccinology. The use of adjuvants – their safety and mode of action – will also be discussed, as will DNA vaccines, Toll-Like Receptors, and novel modes of delivery. In addition, how improved vaccines are targeting infectious diseases will be addressed and updated.

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

2016 ImVacS-Immunization and Vaccine Summit

Download Brochure

2016 Final Agenda

Corporate Sponsors

Avanti Polar Lipids

Precision Nano Systems

Corporate Support Sponsor


View All Sponsors

View Media Partners

Re-Entering Antibacterial Discovery and Development Summit